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Cell migration and antigen capture are antagonistic
processes coupled by myosin II in dendritic cells
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The immune response relies on the migration of leukocytes and on their ability to stop in
precise anatomical locations to fulﬁl their task. How leukocyte migration and function are
coordinated is unknown. Here we show that in immature dendritic cells, which patrol their
environment by engulﬁng extracellular material, cell migration and antigen capture are
antagonistic. This antagonism results from transient enrichment of myosin IIA at the cell
front, which disrupts the back-to-front gradient of the motor protein, slowing down
locomotion but promoting antigen capture. We further highlight that myosin IIA enrichment
at the cell front requires the MHC class II-associated invariant chain (Ii). Thus, by controlling
myosin IIA localization, Ii imposes on dendritic cells an intermittent antigen capture behaviour
that might facilitate environment patrolling. We propose that the requirement for myosin II in
both cell migration and speciﬁc cell functions may provide a general mechanism for their
coordination in time and space.
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D
endritic cells (DCs) are in charge of capturing antigens in
peripheral tissues, transporting them to lymph nodes and
presenting them on major histocompatibility complex
(MHC) molecules to T lymphocytes. This process referred to as
antigen presentation leads to T-cell activation and is essential
for the onset of the adaptive immune response. In tissues,
immature DCs capture antigens mainly by phagocytosis and
macropinocytosis1. This actin-dependent mode of internalization
allows the nonspeciﬁc uptake of large amounts of extracellular
ﬂuid and, in DCs, relies on the small GTPases Cdc42 and Rac1
(refs 2,3). Taken-up antigens are delivered to endolysosomes,
where they are degraded into peptides to be loaded on MHC class
II molecules4.
How immature DCs uptake antigens in vivo to exert their
patrolling function has recently started to be documented.
Two-photon imaging experiments suggest that in certain tissues,
such as the mouse ear and gut, DCs randomly migrate to scan the
environment5,6. In contrast, in the mouse footpad and lung, DCs
were shown to rather remain sessile and uptake luminal antigens
through membrane projections that cross the epithelia7–10.
Whether these different DC behaviours rely on cell-intrinsic
mechanisms that allow the coordination between their antigen
capture function and their migratory capacity remains unknown.
The mechanisms that regulate DC migration are not fully
understood. An essential role was attributed to the actin-based
motor protein myosin II. Its activity is required both ex vivo and
in vivo for migrating DCs to reach their maximal speed in
three-dimensional (3D) environments11,13. Integrin-dependent
adhesion was found to be dispensable to this process11.
Using microfabricated channels that mimic the conﬁned space
of peripheral tissues, we have shown that the MHC class
II-associated invariant chain (Ii or CD74) regulates the motility
of immature DCs by imposing transient phases of slow
locomotion12. In addition, myosin IIA and Ii were found to
physically interact in both DCs and B cells12,14. However, neither
the mechanism by which Ii reduces DC locomotion nor the
impact of such regulation on the antigen capture function of DCs
has been highlighted so far.
Here we show that antigen capture and DC migration both
require myosin IIA. Efﬁcient antigen uptake by macropinocytosis
is associated with periodic enrichments of Myosin IIA at the DC
front. These enrichments disrupt the back-to-front myosin IIA
gradient responsible for fast locomotion and therefore slow down
cell speed. These results indicate that there is a cell-intrinsic
antagonism between fast cell migration and antigen uptake.
We further show that this antagonism relies on the regulation
of myosin IIA localization by Ii, which is required for the
recruitment of the motor protein at the front of DCs. We propose
that this migration mode imposes on immature DCs a migratory
behaviour that might facilitate their ability to detect scattered
antigens, as suggested by a model based on intermittent search
optimization.
5 10 150.8 1.0 1.20.8 1.0 1.2
21
 m
in
Speed (μm min–1)
MyoIIAHC-GFP
Relative MyoIIA front Relative MyoIIA back
Speed (μ
m
 m
in
–1)
M
ea
n 
re
la
tiv
e 
in
te
ns
ity
Time (min)
–6 –4 –2 0 2 4 6
–1
–0.5
0
0.5
1
Lag (min)
Cr
os
s-
co
rre
la
tio
n
Front versus speed
Back versus speed
95% confidence
MyoIIA front MyoIIA back Speed
0 10 20 30
0.7
0.8
0.9
1.0
1.1
1.2
0
5
10
15
20
0.0
0.2
0.4
0.6
0.8
1.0
Sp
ee
d 
flu
ct
ua
tio
ns
(Δ
V/
V
m
e
a
n
)
P<0.001
MyoIIA 
enrichments + –
Figure 1 | Myosin IIA is enriched at the front of DCs during slow motility phases. (a) Sequential epiﬂuorescence images ( 20, one image every minute)
of a myosin IIA-GFP knock-in DC exhibiting one event of myosin IIA-GFP enrichment at the cell front: the average intensity of myosin IIA-GFP at
the front (1) and the back (2) relative to the average intensity of the entire cell were measured together with the cell instantaneous speed (obtained by
tracking the nucleus centre of mass; 3). Scale bar, 10 mm. (b) Quantiﬁcation of speed ﬂuctuations (calculated as s.d./mean instantaneous speed12 in DCs
displaying or not myosin IIA-GFP enrichments at the front within 15min (n¼ 50 cells and 44 cells, respectively, three independent experiments). Data are
represented as box and whiskers (10–90 percentile) plus outliers. A Mann–Whitney test was applied for statistical analysis. (c) Layered curves of the three
parameters described in (a) in a cell undergoing three phases of myosin IIA-GFP enrichment at the cell front. (d) Mean cross-correlation values obtained
from the three parameters measured in (a) in 20 cells that underwent at least one event of myosin IIA-GFP enrichment at the front during motion (two
independent experiments).
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Results
Myosin IIA is enriched at the DC front during slow migration.
We aimed at understanding how myosin II controls the migration
of immature DCs in conﬁned environments. We have previously
shown that in microchannels their speed is compromised by the
addition of the myosin II inhibitor Blebbistatin12. A similar speed
reduction was observed when analysing bone-marrow-derived
DCs differentiated from conditional knockout mice for myosin
IIA, the only myosin II isoform expressed in mouse DCs
(Immunological Genome project http://www.immgen.org)
(Supplementary Figs 1a–e). No further decrease was observed
on Blebbistatin treatment, excluding a compensatory effect by
myosin IIB or IIC (Supplementary Fig. 1e). Migration of myosin
IIA / immature DCs on epidermal ear sheets was equally
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Figure 2 | Myosin IIA enrichment at the front of DCs reduces their speed of locomotion. (a) Schematic of the microﬂuidic device used to deliver drugs at
the front or rear of DCs, composed of migration microchannels (5 5 mm) in between two ﬂuidic chambers. Parallel ﬂows were obtained by ﬁlling the
‘tanks tips’ (with medium-containing drugs or not) but leaving the ‘waste tips’ emptied, leading to the formation of a perpendicular gradient along migration
channels. Clogging of a migration channel by one cell resulted in an on/off drug delivery. (b) Representative kymographs of cells receiving 200mM
Blebbistatin at t¼ 15min either at their front (left), rear (middle) or on both sides (right;  10, one image every 30 s during 55min). Scale bar, 20mm.
(c) Ratio of the mean instantaneous speed measured before and after delivery of Blebbistatin. Data from four independent experiments are represented as
box and whiskers (10–90 percentile) and outliers (30–70 cells per condition). A Kruskal–Wallis test was applied for statistical analysis. (d) Smoothed
instantaneous speed versus ratio of (total myosin IIA-GFP intensity at the cell front)/(total mosin IIA-GFP intensity at the cell rear) before and after
delivery of 50mM para-nitroblebbistatin (non-phototoxic blebbistatin, left panels) or DMSO (right panels) at the front of migrating myosin IIA-GFP
knock-in immature DCs. Cells were classiﬁed in two groups: cells that have high amount of myosin IIA-GFP at their front (upper panels) or cells that have
almost no myosin IIA-GFP at their front (lower panels) before treatment (n¼ 18–20 cells per condition from four independent experiments). (e) Ratio of
the mean instantaneous speed measured before and after delivery of Calyculin A. Data from four independent experiments are represented as box and
whiskers (10–90 percentile) and outliers (30–70 cells per condition). A Kruskal–Wallis test was applied for statistical analysis.
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decreased (Supplementary Fig. 1f,g). We conclude that, as shown
for other types of cells, the migration of immature DCs in
conﬁned environments such as microchannels or the interstitial
space of tissues depends on myosin II-driven contractile forces15.
As previously reported12,13, immature DCs display signiﬁcant
speed ﬂuctuations during motion. To investigate the role of
myosin IIA in this peculiar migration mode, we characterized its
dynamics in DCs differentiated from myosin IIA heavy chain-
green ﬂuorescent protein (GFP) knock-in mice16. We observed
that phases of slow motion were associated with transient events
of myosin IIA enrichment at the DC front (Fig. 1a, amplitude,
duration and frequency quantiﬁed in Fig. 3d–f). Accordingly,
migrating DCs that displayed myosin IIA enrichments at their
front during the observation period also underwent more speed
ﬂuctuations (Fig. 1b). In contrast, myosin IIA was mostly located
at the DC rear during phases of fast motility (Fig. 1a,c and
Supplementary Movie 1). To quantify this phenomenon, we
measured the levels of myosin IIA at the cell rear and front
and evaluated whether these parameters were temporally
cross-correlated with the speed of DCs. This analysis showed
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that slow motility phases systematically correlated with myosin
IIA enrichment at the DC front (Fig. 1d, blue curve) and
myosin IIA reduction at the DC rear (Fig. 1d, pink curve). Hence,
myosin IIA localization at the rear of DCs correlates with fast
migration, whereas myosin IIA enrichment at the front of DCs is
associated with slow locomotion.
Myosin IIA enrichment at the DC front slows down migration.
These data suggest that myosin IIA localization at the DC rear
promotes fast motility, whereas its enrichment at the DC front
slows down migration. To test this hypothesis, we built a
microﬂuidic device in order to selectively modulate myosin II
activity at the rear or front of migrating DCs and evaluated
the impact of such modulation on their speed. For this, we
simultaneously injected culture medium in one chamber and
drug-containing medium in the opposite chamber, resulting in
the formation of a gradient in the microchannels that connect
them (Fig. 2a and Supplementary Fig. 2a, upper panel). Clogging
of microchannels by one cell impaired gradient formation but
resulted in the selective delivery of the drug to one cell pole
(Supplementary Fig. 2a, lower panel)17.
Addition of increasing concentrations of Blebbistatin at the
DC rear reduced their mean instantaneous velocity in a dose-
dependent manner and to a similar extent than inhibition of
myosin II on both cell poles (Fig. 2b,c). Addition of Blebbistatin
at the front of DCs did not signiﬁcantly alter their speed at the
level of the entire cell population. However, we consistently
observed that some DCs that had received Blebbistatin at their
front exhibited decreased speed ﬂuctuations that correlated with
increased cell velocity (Supplementary Fig. 2b). We reasoned that
this differential effect of Blebbistatin might depend on whether
myosin II was enriched or not at the cell front at the time of drug
addition. To test this hypothesis, we used a non-phototoxic
form of Blebbistatin (para-nitroblebbistatin), which impairs cell
migration (Supplementary Fig. 2c) and is compatible with GFP
imaging. We observed that addition of this compound during
phases of myosin IIA-GFP enrichment at the cell front markedly
increased the migration speed of DCs (Fig. 2d, upper left panel,
grey curve). This result indicates that myosin IIA activity
at the cell front indeed impairs cell migration. Noticeably, this
acceleration was accompanied by a reduction in the pool of
myosin IIA-GFP located at the cell front (Fig. 2d, upper left panel,
green curve). No such effects were observed in DCs that did not
show myosin IIA-GFP enrichment at their front at the time of
drug addition (Fig. 2d, lower left panel) or in DCs treated
with dimethylsulphoxide (DMSO; Fig. 2d, upper and lower
right panels). Hence, myosin IIA inhibition at the cell rear
compromises DC migration, whereas myosin IIA inhibition at the
DC front promotes fast motility.
To strengthen these results, we performed similar experiments
using Calyculin A, a phosphatase inhibitor that promotes
myosin II activity by increasing the phosphorylation levels of
its regulatory light chain (myosin light chain (MLC);
Supplementary Fig. 2d)18. Calyculin A had no effect when
applied at the DC rear (Fig. 2e), suggesting that local contractility
cannot be further increased. In contrast, addition of Calyculin A
at the front of DCs strongly decreased their speed, showing that
activation of myosin II at the DC front compromises their
locomotion. Altogether, our results indicate that (1) fast
migration relies on the pool of myosin IIA located at the rear
of DCs and (2) slow migration results from the enrichment of the
motor protein at their front. We therefore conclude that speed
ﬂuctuations observed in migrating immature DCs result from the
repeated disruption of the front-to-back gradient of myosin IIA
because of recruitment of the motor protein to the cell front.
Enrichment of myosin IIA at the DC front requires li. We
aimed at understanding how myosin IIA is recruited at the DC
front. We have previously shown that (1) myosin IIA interacts
with Ii in both B cells and DCs12,14 and (2) Ii-deﬁcient immature
DCs exhibit less speed ﬂuctuations as compared with wild-type
cells12. We therefore hypothesized that myosin IIA recruitment at
the DC front, which triggers phases of slow motion, might be
regulated by Ii. Consistent with this hypothesis, structure
illumination microscopy (SIM) images revealed a partial co-
localization of myosin IIA heavy chain and Ii at both the cell rear
and front of DCs (Supplementary Fig. 3a and Supplementary
Movie 2). This co-localization was quantiﬁed using the
PCR-based ‘Proximity Ligation Assay’, or ‘Duo-Link’19.
A strong positive signal was obtained when labelling GFP and
Ii in myosin IIA-GFP DCs (WT MyoIIAGFP on Fig. 3a,b),
indicating that the two proteins are located at a distance inferior
to 50 nm. This signal was similar to the one measured when
staining for GFP and Ii molecules in MHC class II-GFP knock-in
DCs, MHC class II and Ii being known to directly associate
(WT MHCIIGFP on Fig. 3a). Conversely, Duo-Link signals were
strongly reduced in DCs that do not express Ii or myosin
IIA-GFP (Ii / MyoIIAGFP and B6 on Fig. 3a). The speciﬁcity
of the Ii–myosin IIA interaction was further supported by the
negative signal obtained with the cytosolic protein gamma-
tubulin (Fig. 3a). Quantiﬁcation of the Duo-link-positive signal
showed that Ii and myosin IIA interacted at both the rear
and front of DCs (Supplementary Fig. 3b), conﬁrming the
observations made using SIM.
Figure 3 | Myosin IIA enrichment at the DC front is promoted by Ii. (a) Quantiﬁcation of the Duo-Link signal mean ﬂuorescence intensity on the entire
cell using different DC types and antibody combinations, as indicated. Data are represented as box and whiskers (10–90 percentile) plus outliers. n¼ 12–17
cells per condition from one representative experiment out of three. A Kruskal–Wallis and a Mann–Whitney test was applied for statistical analysis of left
and right panels, respectively. (b) Spinning disk images ( 100, middle plane) of a ﬁxed immature WTmyosin IIA-GFP knock-in DC after PCR-based
Duo-Link ampliﬁcation using anti-Ii and anti-GFP antibodies. Scale bar, 5mm. (c) Sequential epiﬂuorescence pseudocolour images ( 20, one image every
min), of representative myosin IIA-GFP knock-in WT, Ii / and CatS / DCs. Scale bars, 10mm. (d) Amplitude (grey level increment) and (e) duration
of myosin IIA enrichments in myosin IIA-GFP knock-in WT, Ii / and CatS / DCs (n¼ 80, 48 and 55 cells, respectively, four independent
experiments). Bars represent the medians. Littermate controls were used. A Kruskal–Wallis test was applied for statistical analysis. (f) Number of myosin
IIA enrichments per hour, in myosin IIA-GFP knock-in WT, Ii / and CatS / DCs (n¼ 224, 174 and 122 cells, respectively, from eight independent
experiments). A paired t-test was applied for statistical analysis. (g) The median of instantaneous speed of WTor Ii / bone marrow DCs transfected on
day 6 of differentiation with an empty vector (WT-pcDNA3), full-length human Ii (Ii / -IiWT) or human Ii whose leucines 7 and 17 were replaced by
alanines (Ii / -IiL7AL17A). Data from three independent experiments are represented as box and whiskers (10–90 percentile). n¼430 cells per
condition. A Kruskal–Wallis test was applied for statistical analysis. (h) Percentage of DCs exhibiting at least one event of myosin IIA-GFP enrichment at
their front during 1 h of recording and (i) percentage of time spent with myosin IIA-GFP at the front of myosin IIA-GFP knock-in DCs transfected as
described in g. Data from two independent experiments are shown (n¼ 53 WT-pcDNA3, 36 Ii / -pcDNA3, 55 Ii / -IiWT and 67 Ii / -IiL7AL17A
cells). One-way analysis of variance (ANOVA) Bonferroni tests were applied for statistical analysis.
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Having shown that the two proteins physically associate, we
investigated whether Ii regulates myosin IIA localization during
DC migration. For this, we monitored myosin IIA dynamics in
DCs expressing different levels of Ii: DCs knock out for Cathepsin
S (CatS), which are known to accumulate Ii because of impaired
proteolysis20 and Ii-deﬁcient DCs (Fig. 3c and Supplementary
Movie 1). We found that the amplitude, the duration and the
frequency of myosin IIA enrichments were all signiﬁcantly
decreased in Ii-deﬁcient DCs (Fig. 3d–f). In addition, the
percentage of Ii-silenced DCs showing events of myosin IIA
enrichments at their front within 15min was lower as compared
with control DCs (Supplementary Fig. 3c–e), excluding a
bystander effect of Ii gene deletion. These data are consistent
with our previous study showing that Ii / cells display less
speed ﬂuctuations during motion12. In contrast to Ii / DCs,
myosin IIA enrichment events were more frequent in CatS /
DCs, but their amplitude and duration were comparable to the
ones of wild-type (WT) DCs (Fig. 3d–f). These results strongly
suggest that Ii is required for transient myosin IIA enrichments at
the front of migrating DCs. In agreement, we found that ectopic
expression of human Ii (Ii-p33) in mouse Ii / DCs reduced
their speed to WT levels (Fig. 3g) and restored myosin IIA
recruitment at their front (Fig. 3h,i). Strikingly, this was not
observed when using the IiL7A/L17A Ii mutant (Fig. 3g–i), which
was previously shown to remain at the cell surface instead
of reaching endolysosomal compartments (Supplementary
Fig. 3f)21. Consistent with this result, although both WT Ii and
IiL7A/L17A mutant were expressed at similar levels when
transfected in DCs, only WT Ii-p33 and its cleavage
intermediates Ii-p25 and p16 were pulled down with
endogenous myosin IIA-GFP (Supplementary Fig. 3g). We
conclude that Ii triggers the periodic recruitment of myosin IIA
at the DC front and thereby leads to important speed ﬂuctuations.
Myosin IIA at the DC front regulates macropinosome dynamics.
As the main function of immature DCs is to sample their
environment by engulﬁng large amounts of extracellular material,
we next investigated whether the pool of myosin IIA observed at
the DC front plays a role in antigen uptake. For this, we took
advantage of our microﬂuidic device that allows introducing
and rapidly exchanging ﬂuorescent antigens in microchannels
(Supplementary Fig. 4a) in order to follow and quantify the
sequential steps leading to antigen internalization: vesicle
formation (Supplementary Fig. 4b) and antigen arrival to
endolysosomes (Supplementary Fig. 4c). We observed giant
vesicles ﬁlled with extracellular antigens that formed at the
front of DCs, whether ﬂuorescent dextran or ovalbumin (OVA)
were used (Fig. 4a,b and Supplementary Fig. 4b). Washout
experiments combined to lysosome staining showed that the
ﬂuorescent antigens that were retained inside the cell had been
delivered to endolysosomes, where antigen processing takes
place (Supplementary Fig. 4c). The actin-depolymerizing agent
Latrunculin A and the macropinocytosis inhibitor 5-(N-ethyl-N-
isopropyl)amiloride (EIPA)22 or impaired antigen uptake at the
cell front, indicating that antigen-containing vesicles correspond
to macropinosomes (Supplementary Fig. 4d). Such vesicles were
not observed in migrating neutrophils, demonstrating that they
were not a bystander product of conﬁnement inside
microchannels but rather resulted from the strong
macropinocytic capacity of DCs (Supplementary Fig. 4e).
Interestingly, tracking of single macropinosomes at high
temporal resolution in wild-type DCs showed that they emptied
part of their content to the extracellular milieu when reaching the
area in front of the nucleus (see blue vesicle on Fig. 4c and
Supplementary Movie 3). This is consistent with previous
ﬁndings showing that macropinocytosis is associated with
exocytic events that allow membrane recycling and prevent cell
volume increment23.
To deﬁne whether the pool of myosin IIA recruited to the DC
front has an impact on macropinosome formation during
DC migration, we analysed the dynamics of these vesicles
in immature myosin IIA-deﬁcient DCs. Myosin IIA / DCs
displayed macropinosomes that were considerably increased in
number but reduced in volume (Fig. 4d,e). Similar results were
obtained when analysing Ii-deﬁcient DCs, in which myosin IIA is
not efﬁciently recruited at the cell front (Fig. 4e). Noticeably,
characterization of macropinosome dynamics showed that they
underwent a rearward displacement in WT cells, whereas they
were rather static in both myosin IIA / and Ii / DCs
(Fig. 5a,b and Supplementary Movie 4). Accordingly, measure-
ment of macropinosome velocity revealed that it was signiﬁcantly
reduced in both cell types as compared with WT cells (Fig. 5c),
indicating that myosin IIA enrichment at the DC front is required
for intracellular macropinosome trafﬁcking towards the cell rear.
Consistent with these observations, a strong correlation between
the amount of myosin IIA-GFP present at the cell front and the
retrograde velocity of macropinosomes was observed (Fig. 5d).
Interestingly, we found that myosin IIA enrichment at the DC
front was concomitant to events of cell front shortening (Fig. 5a),
suggesting that macropinosome retrograde transport might result
from local myosin II-mediated contraction. We conclude that
myosin IIA regulates macropinosome dynamics at the DC front
by promoting (1) the formation of large macropinosomes and
(2) macropinosome retrograde intracellular transport.
Myosin IIA facilitates antigen delivery to endolysosomes.
We next investigated whether the involvement of myosin IIA in
macropinosome dynamics regulates subsequent events of antigen
transport to endolysosomes. As shown above, these compart-
ments, where antigens are ultimately delivered and processing
takes place, are located behind the nucleus at the rear of
DCs (Supplementary Fig. 4c). To address this question, we
simultaneously monitored myosin IIA enrichment at the cell
front, antigen arrival into endolysosomes and cell speed
(Supplementary Fig. 5a,b). We observed that after antigen loading
into microchannels the ﬁrst peak of antigen arrival to endolyso-
somes was preceded by a cascade of events starting with pro-
gressive myosin IIA enrichment at the DC front ( 10min), cell
front contraction ( 8min, as measured by front length),
cell velocity decrease ( 7min) and macropinosome resorption
( 5min; Fig. 6a and Supplementary Fig. 5c). In addition, cross-
correlation analyses showed that cell front shortening system-
atically correlated with maximal myosin IIA enrichment at the
DC front (Fig. 6b, top panel) as well as with macropinosome
disappearance (Fig. 6b, bottom panel). Together, these results
suggest that myosin IIA enrichment at the front of DCs leads to
local contraction, an event that has two consequences: (1) it
reduces cell speed and (2) it promotes macropinosome resorption
and antigen delivery to endolysosomes.
To conﬁrm the role of myosin IIA in antigen transport, we
monitored the kinetics of antigen arrival into endolysosomal
compartments in DCs that exhibit different levels of myosin IIA
at their front. For this, we labelled the OVA antigen with two
dyes: (1) pH-insensitive AlexaFluor-488 and (2) Cypher5E, which
ﬂuoresces at a pH below 6.4 (refs 24,25; Fig. 7a). Antigen arrival
to endolysosomes, monitored by measuring the AlexaFluor-488
ﬂuorescence in Cypher5E-positive compartments, was visible
10–15min on its addition to the extracellular milieu and
linearly increased during the 90min of recording
(Supplementary Fig. 6a). This antigen accumulation was inhibited
by EIPA, indicating that it strictly relied on macropinocytosis
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(Supplementary Fig. 6b). Strikingly, the ability of myosin IIA /
DCs to accumulate taken-up antigens into endolysosomes was
strongly impaired as compared withWT DCs (Fig. 7b,c, left panel
and Supplementary Movie 5). Ii / DCs, which display low
levels of myosin IIA at their front, also exhibited a defective
antigen accumulation capacity (Fig. 7b,c, middle panel and
Supplementary Movie 5). This is unlikely to result from a global
endocytic defect in Ii / DCs since levels and distribution of
endocytic markers, endosomal pH and ability to transport the
transferrin receptor CD71 to endolysosomes were not altered in
these cells (Supplementary Fig. 6c–h). Hence, myosin IIA
enrichment at the DC front promotes antigen arrival into
endolysosomal compartments. In contrast to Ii knockout DCs,
the ability of CatS-deﬁcient DCs to deliver antigens to
endolysosomes was signiﬁcantly increased (Fig. 7b,c, right panel
and Supplementary Movie 5). We further observed that the ﬁnal
levels of antigen accumulation and the mean instantaneous
velocity of DCs were inversely correlated (Fig. 7d): while most
Ii / DCs clustered in the upper left part of the graph,
indicating that their increased velocity was associated with
impaired antigen accumulation, CatS / DCs clustered in the
lower right part of the graph, showing that their reduced
migration was associated with enhanced antigen capture.
Altogether, our data show that, while myosin IIA localization at
the cell rear promotes fast migration of DCs, its Ii-dependent
transient enrichments at the cell front reduce cell speed but allow
efﬁcient antigen capture, resulting in the coordination of these
two processes in time and space.
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Immature DCs behave as intermittent searchers. We have
shown that immature DCs alternate phases of fast and slow
locomotion, the latter being associated with efﬁcient antigen
capture. Interestingly, this biphasic migration mode is reminis-
cent of ‘intermittent random walks’, which were shown to
minimize the search time of randomly located targets26. The
intermittent random walk model, which so far proved to be
applicable in various contexts, from target search by proteins on
DNA to animal behaviour26–29, relies on the assumption that
efﬁcient probing of the environment by an agent looking for a
target is incompatible with fast motion: search trajectories are in
that case characterized by an alternation of slow motion with high
detection abilities, and fast motion with reduced detection.
This feature qualitatively ﬁts our observations and makes the
intermittent random walk model a natural framework to analyse
the search efﬁciency of immature DCs.
For the sake of simplicity, we consider a DC migrating in a
two-dimensional environment, where antigens are randomly
distributed and interspersed with a mean distance b that
parameterizes their concentration. The DC is assumed to
alternate slow migration phases (i) during which efﬁcient antigen
uptake occurs, and fast migration phases (ii) during which
antigen uptake is neglected. The mean durations of phases (i) and
(ii) are denoted as t1 and t2; the velocity in phase (ii) has a
random direction and modulus v, whereas motion in phase
(i) is neglected in a ﬁrst approximation (Fig. 8a). Following
ref. 26, the efﬁciency of the search process can be quantiﬁed
by the mean search time ot4 for a target, which can be
obtained analytically (see Supplementary Methods). Using the
values of the parameters extracted from cell track analysis and
myosin IIA-GFP dynamics (Fig. 3d–f), we obtained a quantitative
determination of the mean search time (Fig. 8b,c and
Supplementary Methods). t1 and t2 could either be estimated
from the analysis of myosin IIA-GFP enrichment at the cell front
(Fig. 3d–f) or from using a threshold value of 3 mmmin 1 to
deﬁne the slow migration phases, below which DCs efﬁciently
uptake antigens (Fig. 7d), giving similar results. This analysis
yielded a mean search timeot4B15 h for a single cell, and for a
mean distance b¼ 100 mm (WT DCs). It showed that WT cells
perform 30% faster than Ii knockout DCs for a broad range
of antigen concentrations (Fig. 8b). As expected from the
intermittent random walk model, we found that ot4 could be
minimized by adjusting the duration t2 of fast migration phases
(Fig. 8c and Supplementary Fig. 7). Notably, the experimental
value of t2 was found to lie near the theoretical optimum, which
only weakly depends on b, for WT DCs. In contrast, it was
signiﬁcantly larger for li / DCs, indicating that these cells
‘waste time’ in long fast phases of locomotion. This model
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suggests that the observed intermittent behaviour of immature
DCs is kinetically close to optimal for antigen capture in 1D
microchannels.
Discussion
In this work, we show that myosin IIA is transiently and
repeatedly recruited to the front of migrating immature DCs, an
event that promotes efﬁcient antigen capture but slows down
locomotion. How does myosin IIA enrichment at the cell front
reduce DC velocity? Migration under conﬁnement was proposed
to be favoured by a pressure gradient that is strongly enhanced by
myosin IIA back–front polarization. This model predicts that
generation of a contractile force at the cell front should reduce
this pressure gradient and thereby lead to a decrease in cell
velocity30. Our microﬂuidic data showing that myosin IIA
activation at the DC front decreases DC velocity strongly
support this hypothesis. This implies that the loss of speed
observed on recruitment of myosin IIA at the cell front does not
result from a competition for myosin IIA between front and back
but rather from the loss of the myosin IIA activity gradient
required for fast locomotion.
We show that efﬁcient myosin IIA enrichment at the front of
DCs requires Ii, consistent with our previous ﬁndings demon-
strating that Ii-deﬁcient DCs migrate faster and exhibit less
velocity ﬂuctuations than wild-type DCs12. We have previously
shown that myosin IIA and Ii form a protein complex in DCs and
B cells12,14. In addition, super-resolution microscopy as well as
Duo-Link experiments indicate that Ii and myosin IIA are in
close proximity at the cell front, even though their association
occurs all along the cell body. Ii might facilitate the recruitment of
myosin IIA at the DC front through a direct protein–protein
interaction or more indirectly, for example, by locally regulating
actin dynamics or myosin II assembly31. Our ﬁndings that the
IiL7A/L17A Ii mutant, which was shown to remain at the cell
surface instead of reaching endosomes21, did neither associate
with myosin IIA-GFP nor recruit the motor protein at the DC
front suggest that the interaction between both proteins might
take place in endolysosomal compartments. Alternatively, Ii
Leucines 7 and 17 might be involved in its association to the
motor protein. Interestingly, it was recently shown that the
production of PiP3 at the front of polarized amoebas promotes
macropinocytosis but compromises chemotaxis32. Whether Ii
facilitates myosin IIA recruitment at the DC front through a
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direct protein interaction or by modifying local signalling remains
to be explored.
The involvement of myosin IIA in macropinocytosis is
consistent with observations made by others showing that myosin
II is recruited to membrane rufﬂes in other cell types and that
inhibition of MLC phosphorylation compromises the ability of
macrophages to engulf particles33,34. We found that enrichment
of myosin IIA at the DC front allows the retrograde transport
of macropinosomes, indicating that contractile forces provided
by the motor protein might be required for macropinosomes
to be transported inwards and for their content to reach
endolysosomes. Accordingly, cross-correlation analyses indicate
that progressive myosin IIA recruitment at the DC front
ultimately leads to cell front contraction and macropinosome
resorption. These events are followed by the arrival of antigen
into endolysosomes, suggesting that myosin IIA-dependent cell
front contraction allows the delivery of their antigenic content to
endolysosomes. The exact step at which myosin IIA acts to favour
antigen delivery from macropinosomes to endolysosomes
remains to be identiﬁed. Interestingly, we recently showed that
myosin II polarity and activity are controlled by the release of
intracellular calcium from the ER through IP3 receptors13.
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Whether ER calcium also controls macropinosome formation
and antigen transport to endolysosomes shall now be
investigated.
Our work shows that the main function of DCs—antigen
internalization for processing and presentation to T cells—is
coupled to their migratory capacity and antagonizes it. We
propose that coupling between macropinocytosis and DC
migration enables the coordination of these two processes in
time and space. These results are consistent with ﬁndings
showing that DC activation transiently increases antigen uptake
but reduces their motility35. They are further supported by in vivo
two-photon imaging data showing that in the skin, lung and gut
extracellular antigens are internalized by non-motile DCs6,7,10.
We further show that the antagonism between locomotion and
antigen uptake in immature DCs fulﬁls the conditions of
applicability of the intermittent random walk model. Although
our analysis, which relies on parameters extracted from
experiments in a one-dimensional environment, would need to
be conﬁrmed by further in vivo studies, it nonetheless indicates
that the migratory behaviour of immature DCs might facilitate
their antigen search capacity.
In conclusion, this work addresses the unexplored fundamental
question of how cells adapt their migratory behaviour to
efﬁciently perform their effector function(s). We show that, in
immature DCS, the coupling of cell function to cell migration
results from their common requirement for myosin II. As myosin
II controls the motility of many cell types36–39, we foresee that
involvement of this motor protein in other cellular processes (for
example, polarity or gradient sensing) might lead to a coupling of
these processes to cell locomotion.
Methods
Mice. Ii and CatS knockout mice as well as I-Abb-GFP (referred to as MHC
II-GFP) and myosin IIA heavy Chain-GFP knock-in mice (referred to as myosin
IIA-GFP) were previously described12,16. Myosin IIA knockout mice were
generated by crossing MyoIIAﬂox/ﬂox mice40 with CD11c-Cre mice41 and with
Gt(ROSA)26Sor–ﬂox-stop-ﬂox–YFP mice (Rosa-YFP)42 to obtain MyoIIAﬂox/ﬂox-
CD11c-Creþ -Rosa-YFP mice that were used as bone marrow donors. Littermates
or sex- and age-matched MyoIIAwt/wt-CD11c-Creþ -Rosa-YFP mice were used as
control bone marrow donor mice. The breeder mice were previously backcrossed to
C57BL/6 for at least seven generations. The experiments were performed on
6-week-old male or female mice. For animal care, we strictly followed the European
and French National Regulation for the Protection of Vertebrate Animals used for
Experimental and other Scientiﬁc Purposes (Directive 2010/63; French Decree
2013-118). The present experiments, which used mouse strains displaying non-
harmful phenotypes, did not require a project authorization and beneﬁted from
guidance of the Animal Welfare Body, Research Centre, Institut Curie.
Cells. Mouse bone marrow cells were cultured during 10–12 days in medium
supplemented with fetal calf serum and granulocyte–macrophage colony-
stimulating factor-containing supernatant obtained from transfected J558 cells,
as previously described12. To generate neutrophils, we differentiated PLB985
(kindly provided by P. Lutz) with All-trans Retinoic Acid as previously described43.
HEK293Ts were maintained in culture as recommended by the manufacturer
(American Type Culture Collection).
Antibodies and reagents. The following reagents were used for imaging
experiments: CFSE and CMTMR (Molecular Probes), Dextran AlexaFluor-647,
Ovalbumin AlexaFluor-488, WGA AlexaFluor-488 or -647, Hoechst (Life
Technologies), CypHer5E (GE Healthcare) and pHRhodo Red SE (Life
Technologies). For drug treatments, we used EIPA (Life Technologies), Latrunculin
A (Calbiochem), Blebbistatin (Tocris Bioscience), Para-nitroblebbistatin
(Optopharma Ltd), Calyculin A (Sigma), Concanamycin A (Tocris) and DMSO
(VWR). We coated the microchannels with Fibronectin (Sigma). PLB985s were
differentiated with All-trans Retinoic Acid (Sigma). For immunoﬂuorescence,
we used anti-myosin IIA Heavy Chain (Covance, 1/500), AlexaFluor-coupled
(i) τ1
(ii) τ2
v
k
(ii)
WT li –/–
<
t>
 
(m
in)
WT
a
b c
50 100
100
101
102
103
104
105
<
t>
 
(m
in)
101
102
103
104
105
106
107
<
t>
 
(m
in)
101
102
103
104
105
106
107
500 1,000 0 10 20 30 40 50 60 70 80 0 10 20 30 40 50 60 70 80
b (μm) τ2 (min) τ2 (min)
b=50 μm
b=500 μm
b=5,000 μm
b=50 μm
b=500 μm
b=5,000 μm
li –/–
Figure 8 | Ii optimizes the search of antigens by DCs. (a) DC migration as an intermittent random walk: the intermittent random walk model assumes
that DCs alternate between two migration phases (i) and (ii). In the slow phase (i; purple cell), of mean duration t1, cell motion is neglected and antigen
(blue particles) capture occurs at rate k (in all plots we consider the regime k441 of efﬁcient antigen uptake). In the fast phase (ii; blue cell) of
mean duration t2, antigen capture is neglected and cell velocity is v. (b) Antigen mean search time ot4 (log scale) expressed as a function
of the mean distance b between antigen locations. Cell capture radius a¼ 20mm, all other parameters were determined from data shown in Fig. 3.
WT: v¼ 3.9mmmin 1, t1¼ 7.8min, t2¼ 22.2min. li / : v¼ 8mmmin 1, t1¼ 5min, t2¼45min. (c) Mean search time for an antigen expressed as a
function of t2 for different antigen concentrations. Dashed lines highlight the values measured for t2. Parameters as in (b).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8526 ARTICLE
NATURE COMMUNICATIONS | 6:7526 | DOI: 10.1038/ncomms8526 | www.nature.com/naturecommunications 11
& 2015 Macmillan Publishers Limited. All rights reserved.
Phalloı¨din (Invitrogen, 1/200), Atto-425-coupled Phalloidin (Sigma, 1/200),
anti-Ii IN1 (BD Bioscience, 1/50), anti-GFP (Living Colors, Clontech, 1/200),
anti-gTubulin (kind gift from M.Bornens, 1/1,000), anti-Lamp1 (BD Bioscience,
1/500), anti-LYVE-1 (R&D System, 1/1,000), endosomal markers anti-Clathrin HC
(1/100), anti-EEA1 (1/100), anti-Rab11(1/100) and anti-Rab7 (1/50; Cell Signaling
kit), anti-CD71 (Thermo Scientiﬁc, 1/50) and anti-human Ii (PIN1 and BU45
from cell supernatant, 1/2). Slides were mounted with Fluoromount-G (Southern
Biotech). For immunoblot, we used anti-phospho-MLC Thr18/Ser19 (Cell
signaling, 1/1,000), anti-myosin II (Abcam and ECM Bioscience, both at 1/1,000),
anti-myosin IIA Heavy Chain (Covance, 1/1,000), anti-Ii IN1 (BD Bioscience,
1/50), anti-actin (Millipore, 1/1,000) and anti-a-tubulin (Serotec, 1/1,000) and a
homemade puriﬁed rabbit mAb anti-human Ii raised against C-term (C1C2, 1/10).
For ﬂow cytometry, we used a homemade 24G2 anti-Fc Receptor MoAb, rabbit
serum from Agro Bio as a control and the following antibodies: anti-MYH9
(Covance, 1/250), anti-CD11c (HL3 clone, 1/100) and anti-I-Abb (AF6-120.1
clone, 1/100). For lentivirus production, HEK cells were transfected using
GeneJuice (Novagen).
DC imaging on epidermal ear sheets. Epidermal ear sheets were removed from
the ear ventral part, as previously described44. They were stained by adding anti-
LYVE-1 in the culture medium for 1 h at room temperature. In the meantime, WT
and myosin IIA / DCs were stained with CFSE 5 mM and CMTMR 5 mM at 10
millions per ml in PBS for 20min at 37 C, incubated for 5min at 37 C in serum
and washed twice in the culture medium. Overall, 20,000 cells of each cell type were
mixed and loaded on the stained epidermal sheet. After 4 h at 37 C, epidermal
sheets were washed twice with the culture medium to remove residual cells in
suspension that did not penetrate the tissue. Epidermal sheets were imaged using a
spinning disk microscope consisting of Yokagawa CSU-X1 spinning head mounted
on an Eclipse Ti inverted microscope (Nikon) equipped with a Coolsnap HQ2
camera (Photometrics) with a  20 numeric aperture (NA) 0.75 taking one image
every 2min, on a thickness of 100mm.
Preparation of microchannels and speed quantiﬁcation. Microchannels were
prepared as previously described12,45. Brieﬂy, microﬂuidic devices were fabricated
in polydimethylsiloxane using rapid prototyping and soft lithography. PDMS
pieces and glass-bottom ﬂuorodish (World Precision Instruments) were activated
in a plasma cleaner (PDC-32G Harrick) for 30 s and were stuck altogether. They
were then incubated with 20mgml 1 ﬁbronectin for 1 h and washed with PBS. For
velocity quantiﬁcation, cells were loaded into microchannels and imaged during
20 h on an epiﬂuorescence video-microscope Nikon TiE microscope equipped with
a cooled CCD (charge-coupled device) camera (HQ2, Photometrics) with a  10
objective, taking one transmission phase image every 2min. Kymograph extraction
and instantaneous velocity analysis were performed using a homemade programme
as described previously12.
Microﬂuidics for local drug delivery. Microchannels45 with 5 5 mm section and
a length of 800mm were used to deliver drugs at the rear or front of cells. In all,
105 cells per well were loaded and allowed to enter microchannels overnight.
The following day, P1000 tips were placed in each well, tips were ﬁlled with
medium±drugs (tank tips) on one side or left emptied on the other side (waste
tips) to create a ﬂow. During the ﬁrst 15min, medium alone was loaded into the
tank tips ﬁlling the microﬂuidic chambers. It was then removed and replaced by
medium alone on one chamber and drug-containing medium on the opposite
chamber. This resulted in the formation of a gradient in the microchannels that
connect the two ﬂuidic chambers. Cells were recorded during 40min post loading.
Clogging of microchannels by one cell impaired gradient formation but resulted in
the selective delivery of the drug to one cell side. Migrating cells were imaged using
a wide ﬁeld video-microscope Nikon TiE microscope equipped with a cooled CCD
camera (HQ2, Photometrics) with a  10 Ph 0.3 NA. Cell instantaneous velocities
were calculated for each cell before and after drug delivery. To avoid artefacts
induced by ﬂow, the ﬁrst 5min post loading were not considered for speed
measurements. The effect of drugs was assessed by calculating the ratio between the
mean of instantaneous speeds measured before and after drug treatment. For
experiments with para-nitroblebbistatin, we used myosin IIA-GFP knock-in
immature DCs. Total myosin IIA intensity corrected for background was measured
by drawing rectangles at the cell front and at the cell rear for each time point.
The ratio of front/back total myosin IIA intensity was calculated. In parallel,
instantaneous speeds were obtained by tracking the rear of cells and were smoothed
using a ﬂoating window of three time points.
Macropinocytosis dynamics in migrating DCs. Microchannels were modiﬁed to
facilitate the diffusion of dyes and drugs45. Microchannel section was 5 5 mm and
the channels had a length of 350mm. Immature Lifeact-GFP DCs were incubated
for 30min in 200 ng l 1 Hoechst-containing medium, washed and 105cells per well
were loaded and incubated overnight to allow their entry into microchannels. The
following day, treatments for macropinocytosis inhibition were performed by
injecting increasing concentrations of EIPA (20, 50 and 100 mM) 2 h before image
acquisition or increasing concentrations of Latrunculin A (100, 250 and 500 nM)
just before acquisition. Next, 1mgml 1 of 10 kDa AlexaFluor647-Dextran was
loaded in the drug-containing medium and cells were imaged during 2 h using a
wide ﬁeld video-microscope Nikon TiE microscope equipped with a cooled CCD
camera (HQ2, Photometrics) with a  20 Ph 0.75 NA. The volume of dextran
internalized by each cell was quantiﬁed as dextran present inside the cell front
mask given by Lifeact-GFP signal in front of Hoechst signal.
For high-resolution imaging, I-Abb-GFP knock-in cells were imaged using a
spinning disk microscope consisting in a Yokagawa CSU-X1 spinning head
mounted on an Eclipse Ti inverted microscope (Nikon) equipped with a Coolsnap
HQ2 camera (Photometrics) with a  60 objective. 3D stacks and isosurface
reconstruction were obtained using the Imaris 7.2.3 software, allowing the
quantiﬁcation of object volume and number.
OVA delivery to endolysosomes in migrating DCs. AlexaFluor-488 OVA was
coupled to CypHer5E, which ﬂuoresces below pH¼ 6.4. Coupling was performed
following the manufacturer’s manual (GE Healthcare). pH sensitivity of the dye
was checked by measuring the optical density at pH¼ 7.4 in PBS compared with
pH¼ 5.5 in CH3COOH using a NanoDrop (Labtech). Fluorescence of CypHer5E
was only detected at acidic pH. The microﬂuidic device used for this experiment
was equivalent to the one used in macropinocytosis assays. In all, 105 cells per
well were loaded and left overnight to allow their spontaneous entry into micro-
channels. Just before image acquisition, OVA coupled to AlexaFluor-488 and
CypHer5E was added, and cells were immediately imaged using an epiﬂuorescence
video-microscope Nikon TiE microscope equipped with a cooled CCD camera
(HQ2, Photometrics) with a  10 or  20 objective during 90min. Movies were
quantiﬁed using either Imaris 7.2.3 or the Integrated Morphometry Analysis tool of
Metamorph (Molecular Devices). The CypHer5E signal was used as a mask and
applied on the AF488-OVA signal at different time points. The amount of OVA
accumulated in endolysosomes was normalized by the amount of OVA taken up at
the cell front. To address the impact of macropinocytosis inhibition on the ability
of cells to accumulate OVA, DCs migrating along microchannels were pre-treated
with 50 mM EIPA for 2 h. To correlate OVA delivery to endolysosomes along time
to cell instantaneous speed, manual tracking of single cells was performed using the
tracking point plugin of Metamorph.
Cross-correlation analysis. Myosin IIA HC-GFP knock-in DCs were stained,
when indicated, with Hoechst (200 ngml 1) and AlexaFluor555-WGA
(5 mgml 1) for 15min in culture medium at 2 106ml 1. After two washes with
culture medium, they were loaded in microchannels. After 12 h, cells were imaged
at low resolution with an epiﬂuorescence video-microscope Nikon TiE microscope
equipped with a cooled CCD camera (HQ2, Photometrics) with a  20 objective.
When indicated, AlexaFluor647-OVA at 0.5mgml 1 was added to the channels
just before acquisition. Data collection for cross-correlation analysis was carried
out using the Metamorph software (Molecular Devices). Front and back regions
were determined using myosin IIA-GFP signal relative to the position of the
nucleus. Front and back myosin IIA relative intensities correspond to the average
intensity of each region divided by the average intensity of the entire
cell after background subtraction. Accumulation of AlexaFluor647-OVA in
endolysosomes was measured in the AlexaFluor555-WGA mask. Cell speed was
calculated from the position of the nucleus. The normalized cross-correlation
functions between discrete signals f(t) and g(t) (either speed or ﬂuorescence signal
of cells) represent the mean of the normalized cross-correlation function of
individual cells Rfg , which is calculated as follow:
Rfg tð Þ ¼ 1T t
PT  t 1
t¼0
ðf tþ tð Þ f Þðg tð Þ gÞ
sf sg
t  0
Rfg tð Þ ¼ Rgf  tð Þ to0
ð1Þ
where T is the length of the signals and s is the s.d. The 95% conﬁdence threshold
C(t) of correlation coefﬁcients is approximated from the number of products
involved in the correlation coefﬁcients and corrected from the autocorrelation of
signals using the following expression:
CðtÞ ¼ 2LﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP
nðTn  tj jÞ
p ð2Þ
For all cells n, where L is the maximum of autocorrelation lengths between signals
f and g.
Semiautomatic analysis of myosin IIA-GFP enrichments. Myosin IIA
enrichments were analysed using a custom routine written in Matlab (Mathworks)
as following. First, to avoid any noisy detection, a low-pass ﬁlter with a cutoff
frequency of three sampling steps was applied to the raw data (myosin IIA mean
intensity at the front). The initiation of myosin IIA-GFP enrichment events was
detected when the derivative signal became positive. Enrichment amplitude was
calculated as the difference in grey levels between the highest value and the lowest
value of the myosin IIA-GFP mean front intensity. To exclude enrichments due to
steady-state ﬂuctuations of myosin IIA at the front, an amplitude threshold of
10 grey levels was applied. All enrichments automatically detected with this routine
were ultimately conﬁrmed by eye.
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Macropinosome retrograde transport. Myosin IIA-GFP knock-in DCs migrat-
ing into 5 5 mm microchannels coated with 20 mgml 1 ﬁbronectin were imaged
using a spinning disk microscope consisting of Yokagawa CSU-X1 spinning head
mounted on an Eclipse Ti inverted microscope (Nikon) equipped with a Coolsnap
HQ2 camera (Photometrics) with a  60 differential interference contrast 0.75 NA
taking one image every 10 s. Only the cell middle plan was imaged. Macropino-
some velocity was measured over 2min post formation by detection of its initial
and ﬁnal positions. During the same time frame, myosin IIA enrichment was
determined in a region surrounding macropinosomes. To take only into account
myosin IIA enrichment above background, myosin IIA patches were considered as
clusters bigger than 10 pixels above the mean GFP intensity of the cell front GFP
cytoplasmic signal.
Flow cytometry analysis. Cells were resuspended in staining buffer (see above).
After Fc blocking with 24G2 monoclonal Ab, the cell suspension was stained for
20min at 4 C with the indicated antibodies. Cells were then washed three times
and were resuspended in staining buffer. For intracellular staining, cells were ﬁrst
surface-stained as described above, and then permeabilized, ﬁxed and stained with
anti-Myh9 or rabbit serum using the Cytoﬁx/Cytoperm kit from BD Bioscience as
recommended by the manufacturer.
Lentivirus production and infection. For short hairpin RNA (shRNA)
experiments, puriﬁed pLKO.1 lentiviral plasmids carrying shRNA sequences for Ii
(NM_010545.2-718s1c1-CCGGGCGTCCAATGTCCATGGATAACTCGAGTTA
TCCATGGACATTGGACGCTTTTTG for ShIi1 and NM_010545.2-763s1c1–
CCGGCGTTACCAAGTACGGCAACATCTCGAGATGTTGCCGTACTTGGTA
ACGTTTTTG for ShIi2, Sigma-Aldrich) or control shRNA (SHC002–CCGGCG
TGATCTTCACCGACAAGATCTCGAGATCTTGTCGGTGAAGATCACGTT
TTT, Sigma-Aldrich) were used to generate lentiviral particles. Brieﬂy, HEK293T
packaging cells were co-transfected with the transfer plasmid pLKO/shRNA, the
pPAX2 packaging plasmid and the pMD2G envelope plasmid (kind gifts from
D. Trono, EPFL, Lausanne, Switzerland), using the GeneJuice Transfection Reagent
as recommended by the manufacturer (Novagen). Virus supernatants were titered
using the QuickTiter Lentivirus Titer Kit (Cell Biolabs Inc.) and were used to infect
Day2-DCs at a multiplicity of 0.03 pg of p24 per cell by adding it directly to the
culture. The medium was replaced on day 3 and infected cells were selected with
4 mgml 1 puromycin from day 4 to day 6. Several washes were carried out during
the selection process to eliminate dead cells. Infected DCs were used on day 10 for
experiments.
Transfection of BMDCs. Bone-marrow derived dendritic cells (BMDCs) were
transfected using the Amaxa mouse Dendritic Cell Nucleofector Kit (Lonza),
according to the manufacturer’s protocol. BMDCs collected on day 6 of differ-
entiation (3 106) were transfected in 100ml of Amaxa solution containing 2 mg of
plasmid (empty vector: pCDNA3; Ii full length or IiL7AL17A mutant, kindly
provided by Oddmund Bakke). Transfected cells were used for 6–16 h after
transfection. Transfection rate was B40%.
Immunoﬂuorescence. For immunoﬂuorescence on cells migrating in micro-
channels, microchannels were prepared differently: in order to easily detach the
piece of PDMS after cell ﬁxation, only the glass slide surface was activated with
plasma before sticking it to PDMS. DCs were loaded in microchannels and
ﬁxed 12 h later with 4% paraformaldehyde for 20min at room temperature.
After three washes in PBS, PDMS was gently removed and cells were
permeabilized in PBS 1 þ 0.2 %þBSAþ 0.05 % saponin for 10min and stained
with antibodies. All washes and antibody dilutions were performed in the
permeabilization buffer. Slides were washed, mounted and visualized on an
inverted Spinning Disk Confocal Roper/Nikon microscope with a  63 1.4 NA
or a  100 1.4 NA oil immersion objective.
Duo-Link in situ detection of protein complexes. The Duo-Link in situ experi-
ment was performed according to the manufacturer’s recommendations (Olink
Bioscience). Brieﬂy, immature DCs were loaded in microchannels, ﬁxed and per-
meabilized as described in the Immunoﬂuorescence section. DCs were stained with
primary antibodies in permeabilization buffer overnight at 4 C, washed once with
the permeabilization buffer, stained with AlexaFluor488-Phalloidin for 30min and
washed again before the incubation with the secondary antibody. Anti-GFP and
anti-gTubulin antibodies were detected with the commercially available anti-Rabbit
Plus PLA Probe. Anti-Ii antibodies were detected with anti-Rat antibodies coupled
to Minus PLA Probe using the commercially available PLA Probe Maker Kit. Slides
were washed, mounted with Fluoromount and visualized on an inverted Spinning
Disk Confocal Roper/Nikon microscope with a  100 1.4 NA oil immersion
objective. The Duo-Link signal was quantiﬁed as the mean intensity of the overall
cell on the sum projection of z planes with a background subtraction.
Structured illumination microscopy. Structured illumination image acquisition
was carried out using an OMX version 3 (Applied Precision-GE Healthcare,
Issaquah, WA) coupled to three EMMCD Evolve cameras (Photometrics,
Tucson, AZ). Multichannel image alignment was performed using ImageJ
(Rasband, W.S., ImageJ, US National Institutes of Health, Bethesda, MD, USA,
http://imagej.nih.gov/ij/, 1997-2012) and UnwarpJ plugin46. Co-localized pixels
were detected using the RG2B co-localization plug in of Image J.
Immunoblotting. DCs were lysed for 10min in 100mM Tris, 150mM NaCl, 0.5%
NP-40, a protease inhibitor cocktail (Roche) and a phosphatase inhibitor cocktail
(Sigma). Soluble extracts (50 mg) were loaded on a 4–20% TGX gradient gel
(Bio-Rad) and were transferred on a Trans-Blot Turbo PVDF/Nitrocellulose
membrane (Bio-Rad). Membranes were blocked with TBS 0.05% Tween-20þ 5%
BSA, incubated with primary antibodies (1/1,000 anti-phosho-MLC and 1/5,000
anti-a-tubulin), washed and incubated with secondary antibodies (1/5,000
horseradish peroxidase (HRP)-conjugated antibodies). Signals were revealed
with the SuperSignal West Dura substrate (Thermo Scientiﬁc).
Myosin IIA-GFP pull-down. For each condition, 5 106 BMDCs transfected at
day 6 were lysed 8 h post transfection at 4 C in 25mM Tris pH 7.5, 50mM NaCl,
0.1% NP40 and a protease inhibitor cocktail (Roche) during 1 h. Lysates were
incubated with 20 ml of GFP-trap beads (Chromotek) for 5 h at 4 C under rotation,
washed four times in 1ml lysis buffer, dried and resuspended in Laemmli Buffer,
loaded on a 4–20% TGX gradient gel (Bio-Rad) and transferred on a Trans-Blot
Turbo PVDF/Nitrocellulose membrane (Bio-Rad). Membranes were blocked with
PBSþ 0.05 %Tween20þ 5% BSA, incubated with primary antibodies (1/1,000
anti-myosin IIA HC and 1/10 homemade anti-human Ii C-term rabbit serum),
washed and incubated with secondary antibodies (1/5,000 HRP-conjugated
antibodies). Signals were revealed with the SuperSignal West Dura substrate
(Thermo Scientiﬁc).
CD71 pulse-chase experiments and analysis of endosomal compartments. In
all, 3 105 DCs were loaded in microchannels 10 h before the pulse-chase. First,
transferrin receptors (CD71) expressed at the surface were stained at 4 C with
antibodies diluted in medium for 20min. After three washes with medium at 4 C,
DCs were incubated at 37 C for 30min, and then ﬁxed inside micro-channels.
Immunoﬂuorescence was then performed as described above (see Immuno-
ﬂuorescence section) using phalloı¨din-AF546, Hoechst and endosomal markers:
anti-ClathrinHC, anti-EEA1, anti-Rab11, anti-Rab7, anti-Lamp1 and phalloı¨din.
Images were acquired on an epiﬂuorescence Nikon microscope (Eclipse 90i
Upright) with a  100 objective. Deconvolution was performed on stacks of images
taken with a 100-nm z section, using the 3D deconvolution module of META-
MORPH and the fast iterative constrained point spread function-based algo-
rithm47. Quantiﬁcations were performed using Image J. Phalloı¨din staining was
used as a mask for the cell. For endosomal and CD71 staining, foci were detected
by applying a threshold and object segmentation by maxima.
Analysis of lysosomal pH. AlexaFluor-488 OVA was coupled to pHRhodo Red
SE, which ﬂuoresces below pH¼ 6.5 and is quantitatively sensitive to acidic pH.
Coupling was performed following the manufacturer’s manual (Life Technologies).
Overall, 106 DCs were incubated with 0.2mg of pHRhodo Red dye coupled to
AF488-OVA in 1ml of the medium for 1 h at 37 C. After three washes with
medium, DCs were loaded into microchannels with 25 nM Concanamycin A or
DMSO. After 6 h, cells were recorded every 3min on an epiﬂuorescence video-
microscope Nikon TiE microscope equipped with a  20 objective with a cooled
CCD camera (HQ2, Photometrics). The relative lysosomal pH was determined as
the ratio of pHRhodo Red/AF488-OVA mean intensities. For each cell, a mean
ratio on ﬁve frames was calculated.
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Corrigendum: Cell migration and antigen capture
are antagonistic processes coupled by myosin II in
dendritic cells
Me´lanie Chabaud, Me´lina L. Heuze´, Marine Bretou, Pablo Vargas, Paolo Maiuri, Paola Solanes, Mathieu Maurin,
Emmanuel Terriac, Mae¨l Le Berre, Danielle Lankar, Tristan Piolot, Robert S. Adelstein, Yingfan Zhang,
Michael Sixt, Jordan Jacobelli, Olivier Be´nichou, Raphae¨l Voituriez, Matthieu Piel & Ana-Maria Lennon-Dume´nil
Nature Communications 6:7526 doi: 10.1038/ncomms8526 (2015); Published 25 Jun 2015; Updated 14 Aug 2015
Previous work by Ke´piro´ et al. describing the photostable blebbistatin derivative para-nitroblebbistatin was inadvertently omitted
from the reference list of this Article and should have been cited at instances where this inhibitor is referred to. For example, in the
Results section, Ke´piro´ et al. should have been cited as follows: ‘To test this hypothesis, we used a non-phototoxic form of Blebbistatin
(para-nitroblebbistatin), which impairs cell migration (Supplementary Fig. 2c) and is compatible with GFP imaging (Ke´piro´ et al.)’.
Ke´piro´, M. et al. para-Nitroblebbistatin, the non-cytotoxic and photostable myosin II inhibitor. Angew. Chem. Int. Ed. Engl. 53, 8211–8215 (2014).
DOI: 10.1038/ncomms9122
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